265 filings
Page 8 of 14
8-K
ldkw08w
24 Nov 20
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDIĀ® SPRINKLE (hydrocortisone) in the United States
4:38pm
4
iqdot1q3v9n
16 Oct 20
Change in insider ownership
9:30pm
8-K
e7b eu6k7i
16 Oct 20
Eton Pharmaceuticals Announces Closing of Public Offering
5:24pm
424B5
1pvxhcwifcrby1m0
15 Oct 20
Prospectus supplement for primary offering
4:50pm
8-K
plzpu4 m1
15 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
9:15am
8-K
l4w5 4x7mm
14 Oct 20
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
8:53am
424B5
mjbm11drqvo
13 Oct 20
Prospectus supplement for primary offering
4:21pm
8-K
60z11sv7wfu9wmdm5
8 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
9:05am
8-K
oxhwj
6 Oct 20
Other Events
4:56pm
8-K
xwtd44
30 Sep 20
Other Events
6:15am
8-K
89qw u0ib
25 Sep 20
Other Events
8:23am
8-K
5f504p817rlhkse3ld
16 Sep 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:28am
8-K
w522b1q9vr
31 Aug 20
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
9:25am
EFFECT
mbl2akkcvh0g nf
26 Aug 20
Notice of effectiveness
12:15am
CORRESP
r1gxi2rzzt
24 Aug 20
Correspondence with SEC
12:00am
8-K
0404i
12 Aug 20
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:52am
8-K
5rfs5ae1wycbq
11 Aug 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:21am
UPLOAD
h9a ojjkn
4 Aug 20
Letter from SEC
12:00am